Artificial Cornea and Corneal Implants Market to Grow at 7.54% CAGR through 2029
Increasing
awareness about corneal health and the availability of advanced treatment
options is expected to drive the Global Artificial Cornea and Corneal Implants
Market growth in the forecast period, 2025-2029.
According to
TechSci Research report, “Artificial Cornea and Corneal Implants Market – Global
Industry Size, Share, Trends, Competition, Forecast & Opportunities, 2019-2029F”,
the Global Artificial Cornea and Corneal Implants Market stood at USD 444.06 Million in
2023 and is anticipated to project steady growth in the forecast period with a
CAGR of 7.54% through
2029.
The Global
Artificial Cornea and Corneal Implants Market is witnessing significant growth,
driven by a confluence of technological advancements, rising prevalence of
corneal diseases, and increasing awareness about eye health. The market's
expansion is underscored by the growing demand for effective solutions to
address corneal blindness and visual impairment, conditions that affect
millions of people worldwide. The prevalence of corneal diseases such as
keratoconus, Fuchs' dystrophy, and corneal scarring, along with the global rise
in the aging population, is fueling the need for advanced corneal implants.
In recent years,
substantial investments in research and development have led to innovative
solutions in corneal implant technologies. Bioengineered corneas and advanced
polymer-based artificial corneas represent the forefront of these innovations,
offering improved biocompatibility and reduced risk of rejection. The
development of new surgical techniques, such as Descemet's Stripping
Endothelial Keratoplasty (DSEK) and Descemet Membrane Endothelial Keratoplasty
(DMEK), has further enhanced the success rates and recovery times for patients
undergoing corneal implant procedures. These advancements are particularly
significant as they not only improve patient outcomes but also expand the pool
of candidates eligible for corneal implants, thereby driving market growth.
North America
remains the dominant region in the global artificial cornea and corneal
implants market. The United States, with its advanced healthcare
infrastructure, extensive research capabilities, and high healthcare
expenditure, leads the market. The presence of leading ophthalmic research institutions
and medical centers, coupled with substantial funding from government and
private sectors, supports the continuous development and adoption of
cutting-edge corneal treatments. The robust regulatory framework,
while stringent, ensures the introduction of high-quality, reliable products,
fostering a market environment conducive to innovation and growth.
Europe follows
closely, benefiting from a well-established healthcare system, significant
investments in ophthalmic research, and a high prevalence of corneal diseases.
Countries such as Germany, the United Kingdom, and France are at the forefront
of adopting advanced corneal implant technologies, driven by supportive
government policies and funding initiatives aimed at combating visual impairment.
The region's focus on improving healthcare accessibility and patient outcomes
contributes to its strong market position.
The Asia-Pacific
region is emerging as a significant market for artificial corneas and corneal
implants, fueled by the growing prevalence of corneal diseases, increasing
healthcare expenditure, and improving healthcare infrastructure. Countries like
China, India, and Japan are investing heavily in healthcare advancements,
including ophthalmic treatments. The rising awareness about eye health and the
increasing availability of advanced medical technologies are key drivers in
this region. The large population base presents a substantial
patient pool, offering significant growth opportunities for market players.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on
"Global Artificial Cornea and Corneal Implants Market”
The Global Artificial
Cornea and Corneal Implants Market is segmented into type, transplant type,
disease indication, end user, regional distribution, and company.
Based on transplant
type, the Endothelial Keratoplasty techniques have demonstrated superior
long-term graft survival rates and better endothelial cell function, leading to
improved patient satisfaction and reduced need for repeat surgeries. The
evolution of these minimally invasive techniques has revolutionized corneal
transplantation, making it a more viable option for a broader range of
patients, including those with complex corneal diseases such as Fuchs'
endothelial dystrophy and bullous keratopathy.
In addition to
the clinical benefits, Endothelial Keratoplasty techniques have also
contributed to advancements in corneal tissue utilization and eye banking
practices. The selective nature of these procedures allows for more efficient
use of donor corneal tissue, reducing wastage and increasing the availability
of donor tissue for transplantation. This has significant implications for
addressing the global shortage of donor corneas and improving access to corneal
transplantation, particularly in regions with limited healthcare resources. The growing adoption of Endothelial Keratoplasty techniques is supported by
ongoing technological advancements and refinements in surgical instrumentation
and graft preparation methods. These innovations have made the procedures more
accessible and reproducible for ophthalmic surgeons worldwide, contributing to
their widespread acceptance and integration into clinical practice.
Based on region,
Europe holds a prominent position as the second dominant region in the Global
Artificial Cornea and Corneal Implants Market due to several key factors that
contribute to its strong market presence and growth trajectory. Europe
benefits from a well-established healthcare infrastructure characterized by
advanced medical facilities, skilled healthcare professionals, and
comprehensive healthcare systems across many countries within the region. These
factors ensure widespread access to ophthalmic care and facilitate the adoption
of innovative corneal implant technologies. Europe
boasts a rich history of medical research and innovation, with numerous
renowned ophthalmic research institutions, academic centers, and medical device
companies driving advancements in the field of ophthalmology. This robust
research ecosystem fosters collaboration between academia, industry, and
healthcare providers, leading to the development of cutting-edge corneal
implant technologies and surgical techniques. As a result, Europe is at the
forefront of introducing new treatments and devices for corneal diseases,
enhancing patient outcomes and driving market growth.
Europe's strong regulatory framework ensures the safety, efficacy, and quality
of medical devices, including artificial corneas and corneal implants.
Regulatory bodies such as the European Medicines Agency (EMA) and national
health authorities rigorously evaluate new products through comprehensive
review processes, providing assurance to patients, healthcare providers, and
investors. This regulatory environment fosters confidence in the market and
encourages investment in research, development, and commercialization of
corneal implant technologies.
Major companies
operating in Global Artificial Cornea and Corneal Implants Market
are:
- Regeneron Pharmaceuticals, Inc
- Alcon, Inc.
- Bayer AG
- Bausch & Lomb Incorporated
- AJL Ophthalmic S.A.
- CorneaGen Inc.
- Addition Technology, Inc.
- LinkoCare Life Sciences AB
- Presbia plc
- EyeYon Medical Ltd.
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“The future of
the Artificial Cornea and Corneal Implants Market is poised for significant
growth and innovation driven by technological advancements, increasing
prevalence of corneal diseases, and growing demand for effective treatments
worldwide. As research and development efforts continue to focus on improving
biocompatibility, durability, and visual outcomes of artificial corneas,
patients can expect access to safer, more reliable, and customizable implant
options. Advancements in tissue engineering and regenerative
medicine hold promise for addressing challenges such as donor tissue shortages
and immune rejection. With expanding healthcare infrastructure, rising
healthcare expenditure, and heightened awareness about eye health, the market
is expected to witness continued expansion, catering to a broader patient
population and driving improvements in vision restoration and quality of life
globally.,” said Mr. Karan Chechi, Research Director of TechSci Research, a
research-based management consulting firm.
“Artificial
Cornea and Corneal Implants Market - Global Industry Size, Share, Trends,
Opportunity, and Forecast, Segmented By Type (Human Cornea and Artificial
Cornea), By Transplant Type (Penetrating Keratoplasty and Endothelial
Keratoplasty), By Disease Indication (Fuchs’ Dystrophy, Keratoconus, Fungal
Keratitis, Others), By End User (Hospitals, Ambulatory Care Centers, Others),
By Region and Competition, 2019-2029F”, has evaluated
the future growth potential of Global Artificial Cornea and Corneal Implants
Market and provides statistics & information on market size, structure and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Global Artificial Cornea
and Corneal Implants Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com